Compare PFE & CME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFE | CME |
|---|---|---|
| Founded | 1849 | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.6B | 105.1B |
| IPO Year | 2013 | 2002 |
| Metric | PFE | CME |
|---|---|---|
| Price | $24.10 | $223.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $29.29 | ★ $307.42 |
| AVG Volume (30 Days) | ★ 32.6M | 4.1M |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | ★ 6.55% | 3.95% |
| EPS Growth | N/A | ★ 15.41 |
| EPS | 0.47 | ★ 3.18 |
| Revenue | ★ $62,579,000,000.00 | $6,520,600,000.00 |
| Revenue This Year | N/A | $10.08 |
| Revenue Next Year | N/A | $4.40 |
| P/E Ratio | ★ $50.29 | $70.81 |
| Revenue Growth | N/A | ★ 6.37 |
| 52 Week Low | $23.11 | $224.40 |
| 52 Week High | $28.75 | $329.16 |
| Indicator | PFE | CME |
|---|---|---|
| Relative Strength Index (RSI) | 33.34 | 22.74 |
| Support Level | $24.02 | N/A |
| Resistance Level | $26.42 | $275.86 |
| Average True Range (ATR) | 0.56 | 8.18 |
| MACD | -0.20 | -2.91 |
| Stochastic Oscillator | 17.25 | 3.78 |
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.